SEC Form 4 · accession 0001363763-15-000002
RespireRx Pharmaceuticals Inc. · RSPI
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Richard David Purcell Jr.
Officer — SVP - Research and Development
Period of report
Oct 15, 2014
Accepted (ET)
Apr 21, 2015 · 5:04 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000849636
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Oct 15, 2014 | A | 2,000,000 | $0.00 | A | 2,000,000 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Grant of restricted shares for no consideration. The shares vest in four equal installments on January 15, 2015, April 15, 2015, July 15, 2015, and October 15, 2015.